Although Yao et al. discovered that cyclin K controls the β-catenin/cyclin D1 axis as a significant mechanism in lung cancer, more investigation is needed to ascertain whether the distinct role of CCNK in nEAC is due to similar molecular connections. The gene discussed is CCNK; the disease is lung carcinoma.